GENDER DIFFERENCES IN TREATMENT RESPONSE IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH TUMOR NECROSIS FACTOR INHIBITOR: A COHORT STUDY FROM THE DANBIO REGISTRY

Karen Buch Lauridsen; Kirsten Duch; Anders Sandermann Mortensen; René Cordtz; S Kristensen; Merete Lund Hetland; Lene Dreyer

doi:10.1136/annrheumdis-2023-eular.1521

GENDER DIFFERENCES IN TREATMENT RESPONSE IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH TUMOR NECROSIS FACTOR INHIBITOR: A COHORT STUDY FROM THE DANBIO REGISTRY

Karen Buch Lauridsen, Kirsten Duch, Anders Sandermann Mortensen, René Cordtz, S Kristensen, Merete Lund Hetland, Lene Dreyer

Department for Rheumatology and Spine Diseases

Original language	English
Publication date	2023
DOIs	https://doi.org/10.1136/annrheumdis-2023-eular.1521
Publication status	Published - 2023
Event	EULAR 2023 - Milano, Italy Duration: 31 May 2023 → 2 Jun 2023

Conference

Conference	EULAR 2023
Country/Territory	Italy
City	Milano
Period	31/05/2023 → 02/06/2023

Access to Document

10.1136/annrheumdis-2023-eular.1521

Cite this

Lauridsen, K. B., Duch, K., Mortensen, A. S., Cordtz, R., Kristensen, S., Hetland, M. L., & Dreyer, L. (2023). GENDER DIFFERENCES IN TREATMENT RESPONSE IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH TUMOR NECROSIS FACTOR INHIBITOR: A COHORT STUDY FROM THE DANBIO REGISTRY. Annals of the rheumatic diseases, vol. 82, suppl. 1, page 310. Abstract from EULAR 2023, Milano, Italy. https://doi.org/10.1136/annrheumdis-2023-eular.1521

GENDER DIFFERENCES IN TREATMENT RESPONSE IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH TUMOR NECROSIS FACTOR INHIBITOR: A COHORT STUDY FROM THE DANBIO REGISTRY. / Lauridsen, Karen Buch; Duch, Kirsten; Mortensen, Anders Sandermann et al.
2023. Annals of the rheumatic diseases, vol. 82, suppl. 1, page 310 Abstract from EULAR 2023, Milano, Italy.

Research output: Contribution to conference › Conference abstract for conference › Research › peer-review

Lauridsen, KB, Duch, K, Mortensen, AS, Cordtz, R, Kristensen, S, Hetland, ML & Dreyer, L 2023, 'GENDER DIFFERENCES IN TREATMENT RESPONSE IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH TUMOR NECROSIS FACTOR INHIBITOR: A COHORT STUDY FROM THE DANBIO REGISTRY', EULAR 2023, Milano, Italy, 31/05/2023 - 02/06/2023 pp. Annals of the rheumatic diseases, vol. 82, suppl. 1, page 310. https://doi.org/10.1136/annrheumdis-2023-eular.1521

@conference{0c594e2dcf864507a7e9b10141cf97e0,

title = "GENDER DIFFERENCES IN TREATMENT RESPONSE IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH TUMOR NECROSIS FACTOR INHIBITOR: A COHORT STUDY FROM THE DANBIO REGISTRY",

author = "Lauridsen, {Karen Buch} and Kirsten Duch and Mortensen, {Anders Sandermann} and Ren{\'e} Cordtz and S Kristensen and Hetland, {Merete Lund} and Lene Dreyer",

note = "COPECARE; EULAR 2023 ; Conference date: 31-05-2023 Through 02-06-2023",

year = "2023",

doi = "10.1136/annrheumdis-2023-eular.1521",

language = "English",

pages = "Annals of the rheumatic diseases, vol. 82, suppl. 1, page 310",

}

TY - ABST

T1 - GENDER DIFFERENCES IN TREATMENT RESPONSE IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH TUMOR NECROSIS FACTOR INHIBITOR: A COHORT STUDY FROM THE DANBIO REGISTRY

AU - Lauridsen, Karen Buch

AU - Duch, Kirsten

AU - Mortensen, Anders Sandermann

AU - Cordtz, René

AU - Kristensen, S

AU - Hetland, Merete Lund

AU - Dreyer, Lene

N1 - COPECARE

PY - 2023

Y1 - 2023

U2 - 10.1136/annrheumdis-2023-eular.1521

DO - 10.1136/annrheumdis-2023-eular.1521

M3 - Conference abstract for conference

SP - Annals of the rheumatic diseases, vol. 82, suppl. 1, page 310

T2 - EULAR 2023

Y2 - 31 May 2023 through 2 June 2023

ER -